| Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1109 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 827 | 2022 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 703 | 2021 |
| NDM metallo-β-lactamases and their bacterial producers in health care settings W Wu, Y Feng, G Tang, F Qiao, A McNally, Z Zong Clinical microbiology reviews 32 (2), 10.1128/cmr. 00115-18, 2019 | 527 | 2019 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 434 | 2021 |
| Why prokaryotes have pangenomes JO McInerney, A McNally, MJ O'connell Nature microbiology 2 (4), 1-5, 2017 | 381 | 2017 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 358 | 2021 |
| Scientific consensus on the COVID-19 pandemic: we need to act now NA Alwan, RA Burgess, S Ashworth, R Beale, N Bhadelia, D Bogaert, ... The Lancet 396 (10260), e71-e72, 2020 | 337 | 2020 |
| S-variant SARS-CoV-2 lineage B1. 1.7 is associated with significantly higher viral load in samples tested by TaqPath polymerase chain reaction M Kidd, A Richter, A Best, N Cumley, J Mirza, B Percival, M Mayhew, ... The Journal of infectious diseases 223 (10), 1666-1670, 2021 | 276* | 2021 |
| The ecology and evolution of pangenomes MA Brockhurst, E Harrison, JPJ Hall, T Richards, A McNally, C MacLean Current Biology 29 (20), R1094-R1103, 2019 | 263 | 2019 |
| Validated H5 Eurasian real-time reverse transcriptase–polymerase chain reaction and its application in H5N1 outbreaks in 2005–2006 MJ Slomka, T Pavlidis, J Banks, W Shell, A McNally, S Essen, IH Brown Avian diseases 51 (s1), 373-377, 2007 | 232 | 2007 |
| Intestinal carriage of verocytotoxigenic Escherichia coli O157, Salmonella, thermophilic Campylobacter and Yersinia enterocolitica, in cattle, sheep and pigs at slaughter in … AS Milnes, I Stewart, FA Clifton-Hadley, RH Davies, DG Newell, ... Epidemiology & Infection 136 (6), 739-751, 2008 | 202 | 2008 |
| Parallel independent evolution of pathogenicity within the genus Yersinia S Reuter, TR Connor, L Barquist, D Walker, T Feltwell, SR Harris, ... Proceedings of the National Academy of Sciences 111 (18), 6768-6773, 2014 | 201 | 2014 |
| Combined analysis of variation in core, accessory and regulatory genome regions provides a super-resolution view into the evolution of bacterial populations A McNally, Y Oren, D Kelly, B Pascoe, S Dunn, T Sreecharan, M Vehkala, ... PLoS genetics 12 (9), e1006280, 2016 | 197 | 2016 |
| 'Add, stir and reduce': Yersinia spp. as model bacteria for pathogen evolution A McNally, NR Thomson, S Reuter, BW Wren Nature Reviews Microbiology 14 (3), 177-190, 2016 | 179 | 2016 |
| Interaction networks, ecological stability, and collective antibiotic tolerance in polymicrobial infections MGJ de Vos, M Zagorski, A McNally, T Bollenbach Proceedings of the National Academy of Sciences 114 (40), 10666-10671, 2017 | 157 | 2017 |
| Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection SE Darch, A McNally, F Harrison, J Corander, HL Barr, K Paszkiewicz, ... Scientific reports 5 (1), 7649, 2015 | 156 | 2015 |
| Comparison of the biotypes of Yersinia enterocolitica isolated from pigs, cattle and sheep at slaughter and from humans with yersiniosis in Great Britain during … A McNally, T Cheasty, C Fearnley, RW Dalziel, GA Paiba, G Manning, ... Letters in Applied Microbiology 39 (1), 103-108, 2004 | 151 | 2004 |
| The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: the complexity of clones and plasmids SJ Dunn, C Connor, A McNally Current opinion in microbiology 51, 51-56, 2019 | 148 | 2019 |
| Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains … G Croxall, J Hale, V Weston, G Manning, P Cheetham, M Achtman, ... Journal of Antimicrobial Chemotherapy 66 (11), 2501-2508, 2011 | 133 | 2011 |
Jukka CoranderUiO, Wellcome Sanger Institute, University of Helsinki在 medisin.uio.no 的电子邮件经过验证
